One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Focus on device innovation in interventional cardiology and on trials in cardiovascular prevention
doi : 10.1093/eurheartj/ehae180
Volume 45, Issue 13, 1 April 2024
Ten tips for promoting cardiometabolic health and slowing cardiovascular aging
Leveraging epitranscriptomics for cardiovascular disease theranostics
The 2023 ESC guidelines for the management of cardiomyopathies: the 10 commandments
A new RNA-interference based strategy is associated with mild beneficial effects in patients with heart failure due to cardiac amyloidosis
Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table
Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial
Transcatheter vs. surgical treatment of aortc stenosis: long awaited long-term data, yet a long way to go
Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: the CardioRACE trial
A new dawn of managing cardiovascular risk in obesity: the importance of combining lifestyle intervention and medication
Discontinuation vs. continuation of renin–angiotensin system inhibition before non-cardiac surgery: the SPACE trial
Pre-operative withdrawal of renin–angiotensin inhibitors: time to re-visit current guidelines
Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial
To transplant or not to transplant ‘marginal’ donor hearts: is machine perfusion the answer?
Machine perfusion of marginal donor hearts: a valuable tool, but where and for whom?
Spontaneous kissing stent for total occlusion of the left main trunk complicated by Stanford Type A aortic dissection
Fibrosing mediastinitis manifesting as refractory pleural effusion and severe pulmonary hypertension successfully treated by percutaneous pulmonary vein stenting
Correction to: 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)
